(Q52006165)
Statements
1 reference
A multicenter double-blind study of controlled-release physostigmine for the treatment of symptoms secondary to Alzheimer's disease. Physostigmine Study Group. (English)
1 reference
Knopman D
1 reference
Thal LJ
1 reference
Schwartz G
1 reference
Sano M
1 reference
Weiner M
1 reference
Harrell L
1 reference
Bodenheimer S
1 reference
Rossor M
1 reference
Philpot M
1 reference
Schor J
1 reference
Goldberg A
1 reference
1 December 1996
1 reference
1 reference
47
1 reference
1389-1395
1 reference
6
1 reference
Identifiers
1 reference
1 reference